Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV000990178 | SCV001141026 | pathogenic | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV002473161 | SCV002771719 | pathogenic | not provided | 2022-07-20 | criteria provided, single submitter | clinical testing | The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). This variant has been identified in at least one individual with CADASIL. This variant alters a critical location within the protein, and is expected to severely affect function and cause disease. Greater than 90% of pathogenic variants identified in NOTCH3 involve the gain or loss of a cysteine residue within the epidermal growth factor (EGF)-like repeat domain. |
Mayo Clinic Laboratories, |
RCV002473161 | SCV005413342 | likely pathogenic | not provided | 2023-11-15 | criteria provided, single submitter | clinical testing | PP2, PP4, PM1, PM2 |